The responsibilities and procedures applicable to the quality control unit are not fully followed.
Inspection Record
Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. — FDA 483 Findings
Inspectors Khoa Nathan V Tran · Lillian S WuThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Equipment and utensils are not cleaned at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.
There is a failure to thoroughly review the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Guangxi Yulin Pharmaceutical Group Co. Ltd.2025-03-21 · US FDASimilar to finding 2 Equipment and utensils are not cleaned at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality, or purity of…
- Huangshi Hygenic Material Medicine Co.2024-08-30 · US FDASimilar to finding 2 Equipment and utensils are not cleaned and maintained at appropmiate intervals to prevent contamination that would alter the safety, identity, strength…
- Lyophilization Services of New England, Inc. dba PCI Pharma Services2026-06-10 · US FDASimilar to finding 2 Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent malfunctions and contamination that would alter the safety, identity…
- Phoenix Innovative Healthcare Manufactures Private Limited2024-09-27 · US FDASimilar to finding 3 There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications…
- Glenmark Pharmaceuticals Inc USA2022-05-19 · US FDASimilar to finding 3 There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch or any of its components to meet any of its specifications…
A record as of the US FDA document published on 2026-11-13. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.